Aventis Pharma ltd t/a Sanofi

Information

Name

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

https://www.sanofi.co.uk/

Address

Reading

United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Aventis Pharma ltd t/a Sanofi
Sign up free

Contracts awarded to Aventis Pharma ltd t/a Sanofi

The contracts that Aventis Pharma ltd t/a Sanofi have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 2 months ago

NHS National Generic Pharmaceuticals Wave 15b

NHS National Pharmaceuticals Generic Products – Wave 15b Offer reference number: CM/PHG/23/5698 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/23/5698/01 – Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st October 2025 to 31st May 2027 (20 months) NWLN: (Northwest and London North): 1st October 2025 to 31st May 2027 (20 months) LSNE: (London South and Northeast): 1st October 2025 to 31st May 2027 (20 months) CM/PHG/23/5698/02 – Hospital Only Products DCE (Midlands) & DSW (Southwest): 1st October 2025 to 30th September 2027 (24 months) CM/PHG/23/5698/03 – Hospital Only (Housekeeping) Products DLS (London South) & DNE (Northeast): 1st October 2025 to 31st May 2026 (8 months) DNW (Northwest) & DLN (London North): 1st October 2025 to 31st January 2027 (16 months) DCE (Midlands) & DSW (Southwest): 1st October 2025 to 31st May 2026 (8 months)

£147
Award

Published 3 months ago

Gastrointestinal, Endocrine, Nutrition & Blood Medicines

This Framework Agreement is for the supply of Gastrointestinal, Endocrine, Nutrition & Blood Medicines to health boards across NHS Scotland. The Goods have been split into fourteen (14) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

£48,954,512
Award

Published 3 months ago

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS Framework Agreement for Branded Medicines - Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 Offer reference number: CM/PHR/24/5718 CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines - Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines - Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months.

£261,895,933 Bids close: 7 months ago
Award

Published 3 months ago

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines – Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027 CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines – Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026

£29
Award

Published 5 months ago

NP35925 Cardiovascular & Respiratory Medicines

This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into nineteen (19) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

£82,305,880
Award

Published 6 months ago

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025 Offer reference number: CM/PHR/22/5683 NHS Framework Agreement for Branded Medicines - Proprietary Category Tender: Period of Framework Agreement: 01 May 2025 to 30 April 2029

£1,241,520,444 Bids close: 10 months ago

Contacts

+44 1234567890

Statistics (1 Year)

Contracts Won

Total Won

£1

Average Win

£1

Aventis Pharma ltd t/a Sanofi

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Aventis Pharma ltd t/a Sanofi

NHS National Generic Pharmaceuticals Wave 15b

Gastrointestinal, Endocrine, Nutrition & Blood Medicines

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025

NP35925 Cardiovascular & Respiratory Medicines

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win